Last Updated: June 23, 2026

FERRIC Drug Patent Profile

Name: FERRIC Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Ferric patents expire, and what generic alternatives are available?

Ferric is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in FERRIC is ferric citrate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ferric citrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ferric

A generic version of FERRIC was approved as ferric citrate by TEVA PHARMS USA on March 11^th, 2026.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for FERRIC?
What are the global sales for FERRIC?
What is Average Wholesale Price for FERRIC?

Summary for FERRIC

US Patents:	0
Applicants:	1
NDAs:	1
DailyMed Link:	FERRIC at DailyMed

Drug patent expirations by year for FERRIC

US Patents and Regulatory Information for FERRIC

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Pharms Usa	FERRIC CITRATE	ferric citrate	TABLET;ORAL	212563-001	Mar 11, 2026	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for FERRIC

Ferric derisomaltose synthesis?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.